Ach-Mycophenolate 500 mg

ACH-Mycophenolate 500 MG tablets are an immunosuppressant medication used to prevent organ rejection after transplants. This oral medication is manufactured by Accord Healthcare Inc. in Canada.

ACH-Mycophenolate 500 MG tablets are primarily used to prevent rejection in organ transplant patients. Mycophenolate is often prescribed to help the body accept the new organ by suppressing the immune system's natural response. This medication is commonly used in kidney, heart, and liver transplant patients. What is mycophenolate used for? It is used to manage the body's immune response to transplanted organs.

Common effects of ACH-Mycophenolate 500 MG tablets may include nausea, vomiting, diarrhea, and abdominal pain. Some users may experience fatigue, headache, or infections. These effects can vary from person to person and may not affect everyone who takes the medication.

ACH-Mycophenolate 500 MG tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication can increase the risk of infections and certain types of cancer, so regular monitoring is recommended.

ACH-Mycophenolate 500 MG tablets may interact with other medications, including antiviral drugs, cholesterol-lowering agents, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while taking this medication.